SUPN

NASDAQStock

Supernus Pharmaceuticals, Inc.

$50.76-2.46 (-4.62%)

52-Week Range

$30.29

$57.00

Key Stats

Market Cap

2.9B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Volume

278.0K

Avg Volume

858.1K

Performance

-1.71%

+6.73%

+14.71%

YTD

+2.00%

+61.89%

+38.78%

+88.28%

Price Chart

ETF Exposure

SUPN is held by 131 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DFUS	Dimensional - US Equity Market ETF	0.01%	16,755	$899K	$18.80B	0.09%
ESGV	Vanguard ESG U.S. Stock ETF	0.01%	12,019	$579K	$11.90B	0.09%
FNDB	Schwab Fundamental U.S. Broad Market Index ETF	0.01%	988	$53K	$1.14B	0.25%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.01%	78,210	$4.2M	$81.53B	0.03%
SCHB	Schwab U.S. Broad Market ETF	0.01%	32,175	$1.7M	$38.14B	0.03%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.01%	10,642	$572K	$12.10B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	13,186	$708K	$17.58B	0.20%
VTHR	Vanguard Russell 3000 ETF	0.00%	4,634	$223K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	1,715,651	$82.6M	$2.10T	0.03%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	40	$2K	$26.4M	0.50%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	846	$41K	$1.46B	0.24%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	35	$2K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	29	$2K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	19	$1K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	14	$777	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	6	$345	$9.5M	0.12%
VT	Vanguard Total World Stock ETF	0.00%	36,885	$1.8M	$80.60B	0.06%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	1,285	$69K	$2.84B	0.19%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	387	$21K	$1.69B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	1,119	$60K	$3.28B	0.20%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	26	$1K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	29	$2K	$64.1M	0.11%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	126	$7K	$733.2M	0.20%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	5	$244	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	15	$807	$81.5M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	172	$9K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	172	$9K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	172	$9K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	172	$9K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	172	$9K	$3.7M	0.70%

PreviousPage 3 of 3

About SUPN ETF Exposure

Supernus Pharmaceuticals, Inc. (SUPN) is held by 131 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.9B, SUPN is a widely held institutional stock. The stock currently trades at $50.76. Investors can gain exposure to SUPN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SUPN, sorted by portfolio weight.